Investment Trusts

International Biotechnology Trust

IBT:LSE

International Biotechnology Trust

Actions
  • Price (GBX)726.00
  • Today's Change16.00 / 2.25%
  • Shares traded144.51k
  • 1 Year change+30.58%
  • Beta0.1759
Data delayed at least 20 minutes, as of Nov 11 2024 16:35 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Total returns on £1000

1Y
Fund/benchmarkChange
PriceInternational Biotechnology Trust (Ordinary Share)+33.47%
NAVInternational Biotechnology Trust (Ordinary Share)+39.31%
Morningstar's BenchmarkNasdaq Biotechnology Index--

Key statistics

International Biotechnology Trust (IBT:LSE) set a new 52-week high during today's trading session when it reached 732.00. Over this period, the share price is up 28.72%.
52-week range
Today
555.00Nov 13 2023732.00Nov 11 2024
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Shares outstanding36.45m
Market cap258.46m GBP
Total assets329.96m GBP
Total expense ratio1.16%
High732.00
Low718.00
Previous close710.00
Average volume182.19k
YTD Change+13.08%
Beta0.1759
Diluted NAV (est)822.31
Diluted NAV (last pub)809.59
Premium/Discount-11.71%
Net Gearing+9.89%
Annual div (ADY)28.40
GBX
Annual div yield (ADY)4.00%
Div ex-dateJul 25 2024
Div pay-dateAug 23 2024
Data delayed at least 20 minutes, as of Nov 11 2024 16:35 GMT.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.